Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCINE.L Regulatory News (CINE)

  • There is currently no data for CINE

Trading Statement

7 Jan 2010 07:00

RNS Number : 1551F
Cineworld Group plc
07 January 2010
Β 

ο»Ώ

7thΒ January 2010

CINEWORLD GROUP PLCΒ Β Pre Close Trading UpdateΒ 

Cineworld Group plc ("Cineworld" or the "Group") plans to publish its preliminary results for the twelve months ended 31 December 2009 on 11Β March 2010. Prior to entering its close period, Cineworld is pleased to announce the following pre-close trading update.Β 

Revenues for theΒ 53 weeks toΒ 31Β DecemberΒ 2009:

53 weeksΒ % change

vs. prior yearΒ 

(52 weeks)

Proforma 52 weeks

% change vs. prior

year (52 weeks)

Total Revenues

+Β 11.4%Β 

+ 9.3%

Box Office

+Β 16.8%Β 

+ 14.6%

Retail

+Β 9.6%

+ 7.6%

Other Income

-Β Β 27.3%

- 28.7%

TheΒ UKΒ andΒ IrelandΒ cinema industry enjoyed another good year in 2009 with industry box office up 11% against the previous year, according to information collated by Nielsen EDI. This box office growth was underpinned by a strong release schedule, which included "Slumdog Millionaire", "TheΒ Twilight Saga: New Moon", "Transformers: Revenge of the Fallen" andΒ "Harry Potter and the Half Blood Prince"Β and a number of 3D releases, the most notable being "Bolt", "Monsters v Aliens", "Ice Age3",Β "UP"Β and "Avatar". The number and success of films released in 3DΒ hasΒ raised the profile of this format, which in turn has had a favourable effect onΒ cinemaΒ admissions.Β 

Our digital expansionΒ hasΒ continuedΒ toΒ deliver good results and the Group hasΒ capitalised on the increasing number ofΒ 3DΒ films released. ThisΒ has contributed to growth inΒ our overall box officeΒ market share in UK/Ireland toΒ 23.9%Β duringΒ the period (Source: EDI Neilsen). Given the challenging consumer environment,Β the growth in the Group's box office and retail revenues reflects a strong performance and the broad appeal of Cineworld's overall offer and value propositions. The performance in these two core revenue streams has more than compensated for the decline in Other Income, principally screen advertising revenue, which reflected generally weak advertising demand. While cost pressures have continued, overall profit performanceΒ is expected to beΒ in line with market expectations.

The GroupΒ remainsΒ highly cash generativeΒ with a strongΒ balance sheet.Β In October Cineworld opened itsΒ first cinemas with all digital projectors, a 10 screen cinema inΒ AberdeenΒ and a 5 screen cinema in Witney. Both cinemas have had very strong openings. These two new cinema complexes increase the Group's estate to 790 screens at 77 locations. Development plans for further new cinemas are in place, although the timingΒ of these openings is still to be defined.

TheΒ film release programme for 2010 looks promising. Anticipated blockbusters includeΒ "Harry Potter and the Deathly Hallows (part 1)", "Shrek 4 (2D & 3D)", "Alice in Wonderland (in 3D)", "Toy Story 3 (2D & 3D)", "Sex And The City 2", "Iron Man 2" and "The Twilight Saga: Eclipse". This and our operating results in 2009 give us confidence in Cineworld's performance going into the year ahead.

-Ends-

For further information:

Richard Jones 020 8987 5000

Chief Financial Officer

Cineworld Group plc

GeorginaΒ Briscoe 020 7920 2348

M:Communications


This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBRGDBIXGBGGL
Date   Source Headline
15th Apr 20205:05 pmRNSHolding(s) in Company
15th Apr 20204:52 pmRNSLong Term Incentive Plan Awards
14th Apr 20201:01 pmRNSHolding(s) in Company
9th Apr 20204:23 pmRNSChange in Director’s Details
9th Apr 20209:24 amRNSHolding(s) in Company
8th Apr 20205:10 pmRNSAnnual Report and Notice of Annual General Meeting
7th Apr 20207:00 amRNSCOVID-19 Update and Suspension of Dividend
2nd Apr 20205:31 pmRNSHolding(s) in Company
1st Apr 20201:58 pmRNSHolding(s) in Company
23rd Mar 20205:55 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 202012:34 pmRNSHolding(s) in Company
23rd Mar 202012:33 pmRNSHolding(s) in Company
23rd Mar 202012:07 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:03 pmRNSPrice Monitoring Extension
20th Mar 20205:46 pmRNSHolding(s) in Company
20th Mar 202012:07 pmRNSSecond Price Monitoring Extn
20th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
18th Mar 20204:59 pmRNSDirector/PDMR Shareholding
16th Mar 20204:07 pmRNSHolding(s) in Company
16th Mar 20209:48 amRNSDirectorate Change
13th Mar 20204:40 pmRNSSecond Price Monitoring Extn
13th Mar 20204:35 pmRNSPrice Monitoring Extension
12th Mar 20201:28 pmRNSHolding(s) in Company
12th Mar 202012:08 pmRNSSecond Price Monitoring Extn
12th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 20207:30 amRNSDean Moore Dignity plc appointment
12th Mar 20207:00 amRNSPreliminary Results 2019
9th Mar 20207:16 amRNSMajor shareholder to refinance margin loan
6th Mar 20207:27 amRNSCompany Update
4th Mar 20205:15 pmRNSHolding(s) in Company
4th Mar 20205:13 pmRNSHolding(s) in Company
11th Feb 20203:51 pmRNSResults of General Meeting
6th Feb 20203:33 pmRNSDirector/PDMR Shareholding
4th Feb 202012:46 pmRNSHolding(s) in Company
28th Jan 20204:48 pmRNSHelen Weir Greencore Group plc appointment
24th Jan 20203:18 pmRNSPublication of Class 1 Circular
21st Jan 20202:23 pmRNSHolding(s) in Company
17th Jan 20202:39 pmRNSHolding(s) in Company
17th Jan 20202:10 pmRNSDirector/PDMR Shareholding
24th Dec 201910:22 amRNSDirector/PDMR Shareholding
20th Dec 20195:43 pmRNSInterim Dividend - Exchange Rate
19th Dec 20192:59 pmRNSDirector/PDMR Shareholding
18th Dec 20191:52 pmRNSHolding(s) in Company
16th Dec 20197:00 amRNSProposed C$2.8bn/US$2.1bn acquisition of Cineplex
3rd Dec 20197:00 amRNSTrading Statement
19th Nov 20193:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.